{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:21:53Z","timestamp":1777576913653,"version":"3.51.4"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01176","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:35:08Z","timestamp":1528115708000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200\u2013CD200R Immune Inhibitory Axis"],"prefix":"10.3389","volume":"9","author":[{"given":"Rakesh K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivas","family":"Gannavaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevien","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallikarjuna Rao","family":"Gedda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira L.","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: current status of available drugs and new potential drug targets","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pac J Trop Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1016\/S2214-109X(14)70318-3","article-title":"Research priorities for elimination of visceral leishmaniasis","volume":"2","author":"Matlashewski","year":"2014","journal-title":"Lancet Glob Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","article-title":"Leishmaniasis: vaccine candidates and perspectives","volume":"30","author":"Singh","year":"2012","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nylen","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25703","DOI":"10.1074\/jbc.M402794200","article-title":"Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania","volume":"279","author":"Selvapandiyan","year":"2004","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","article-title":"Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum","volume":"33","author":"Fiuza","year":"2015","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"33059","DOI":"10.1038\/srep33059","article-title":"Gene deleted attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs","volume":"14","author":"Avishek","year":"2016","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0004322","DOI":"10.1371\/journal.pntd.0004322","article-title":"Intradermal Immunization of Leishmania donovani centrin knock-out parasites in combination with salivary protein LJM19 from sand fly vector induces a durable protective immune response in hamsters","volume":"10","author":"Fiuza","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fimmu.2016.00187","article-title":"Modulation of innate immune mechanisms to enhance Leishmania vaccine-induced immunity: role of coinhibitory molecules","volume":"7","author":"Gannavaram","year":"2016","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.coi.2013.03.003","article-title":"Manipulating the PD-1 pathway to improve immunity","volume":"25","author":"Kamphorst","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1182\/blood-2012-02-412510","article-title":"Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention","volume":"120","author":"Norde","year":"2012","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.coi.2012.01.002","article-title":"CD200R signaling in tumor tolerance and inflammation: a tricky balance","volume":"24","author":"Rygiel","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors"},{"key":"B23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.molimm.2007.07.013","article-title":"The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes","volume":"45","author":"Rijkers","year":"2008","journal-title":"Mol Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.4049\/jimmunol.171.6.3034","article-title":"Characterization of the CD200 receptor family in mice and humans and their interactions with CD200","volume":"171","author":"Wright","year":"2003","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"682168","DOI":"10.5402\/2012\/682168","article-title":"CD200:CD200R-mediated regulation of immunity","volume":"2012","author":"Gorczynski","year":"2012","journal-title":"ISRN Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.4049\/jimmunol.0901531","article-title":"Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells","volume":"183","author":"Mihrshahi","year":"2009","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1615\/CritRevImmunol.v26.i3.20","article-title":"Is the CD200\/CD200 receptor interaction more than just a myeloid cell inhibitory signal?","volume":"26","author":"Minas","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4049\/jimmunol.176.1.191","article-title":"Regulation of myeloid cell function through the CD200 receptor","volume":"176","author":"Jenmalm","year":"2006","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1074-7613(00)00023-6","article-title":"Lymphoid\/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function","volume":"13","author":"Wright","year":"2000","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/01.TP.0000152118.51622.F9","article-title":"Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R","volume":"79","author":"Gorczynski","year":"2005","journal-title":"Transplantation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.4049\/jimmunol.0900252","article-title":"Lack of CD200 enhances pathological T cell responses during influenza infection","volume":"183","author":"Rygiel","year":"2009","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.chom.2010.08.005","article-title":"Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia","volume":"8","author":"Mukhopadhyay","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1128\/JVI.07168-11","article-title":"Suppression of antigen-specific T cell responses by the Kaposi\u2019s sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200","volume":"86","author":"Misstear","year":"2012","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2008.10.008","article-title":"Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction","volume":"131","author":"Sarangi","year":"2009","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2011.04.014","article-title":"Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200","volume":"9","author":"Cortez","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0004963","DOI":"10.1371\/journal.pntd.0004963","article-title":"Live attenuated Leishmania donovani centrin knock out parasites generate non-inferior protective immune response in aged mice against visceral leishmaniasis","volume":"10","author":"Bhattacharya","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1700674","article-title":"Live attenuated Leishmania donovani centrin gene-deleted parasites induce IL-23-dependent IL-17-protective immune response against visceral leishmaniasis in a murine model","volume":"200","author":"Banerjee","year":"2018","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1101\/sqb.2013.78.019869","article-title":"Programme cell death 1-directed immunotherapies for enhancing T cells functions","volume":"78","author":"Akari","year":"2014","journal-title":"Cold Spring Harb Sym Quant Bio"},{"key":"B42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.2180","article-title":"Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection","volume":"13","author":"Butler","year":"2011","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"B21","DOI":"10.1016\/j.vaccine.2014.12.082","article-title":"Beyond adjuvants: immunomodualation strategies to enhance T cell immunity","volume":"8","author":"Kanphorst","year":"2015","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-3024.2009.01094.x","article-title":"Evaluation of T cell responses in healing and nonhealing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro","volume":"31","author":"Choi","year":"2009","journal-title":"Parasite Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.4049\/jimmunol.1303145","article-title":"Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana","volume":"193","author":"Dey","year":"2014","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-12-800100-4.00005-2","article-title":"The CD200-CD200R1 inhibitory signaling pathway: immune regulation and host-pathogen interactions","volume":"121","author":"Vaine","year":"2014","journal-title":"Adv Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","article-title":"Mechanisms of immune evasion in leishmaniasis","volume":"82","author":"Gupta","year":"2013","journal-title":"Adv Appl Microbiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2217\/fmb.14.43","article-title":"Immunity to visceral leishmaniasis: implications for immunotherapy","volume":"9","author":"Khadem","year":"2014","journal-title":"Future Microbiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nylen","year":"2007","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.imbio.2008.07.001","article-title":"Identification of regulatory T cells during experimental Leishmania infantum infection","volume":"214","author":"Rodrigues","year":"2009","journal-title":"Immunobiology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e2995","DOI":"10.1371\/journal.pntd.0002995","article-title":"Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-beta in early immune response","volume":"8","author":"Guha","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","article-title":"B7-H1 blockade increases survival for dysfucntional CD8+ T cells and confer protection against Leishmania donovani infection","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog"},{"key":"B57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.coi.2006.03.020","article-title":"Differentiation of memory B and T cells","volume":"18","author":"Kalia","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/82_2010_116","article-title":"Role of PD-1 in regulating T-cell immunity","volume":"350","author":"Jin","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1371\/journal.pntd.0000871","article-title":"CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists","volume":"4","author":"Hernandez-Ruiz","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.4049\/jimmunol.1202537","article-title":"Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion","volume":"190","author":"Mou","year":"2013","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.4049\/jimmunol.1301810","article-title":"Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function","volume":"191","author":"Esch","year":"2013","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e35466","DOI":"10.1371\/journal.pone.0035466","article-title":"Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells","volume":"7","author":"Caserta","year":"2012","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"631460","DOI":"10.1155\/2012\/631460","article-title":"Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites","volume":"2012","author":"Selvapandiyan","year":"2012","journal-title":"J Trop Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(13)70551-5","article-title":"Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial","volume":"15","author":"Westin","year":"2014","journal-title":"Lancet Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S1470-2045(13)70381-4","article-title":"Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial","volume":"14","author":"Calabro","year":"2013","journal-title":"Lancet Oncol"},{"key":"B66","unstructured":"Antibodies to Ox-2\/Cd200 and Uses Thereof"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e39757","DOI":"10.1371\/journal.pone.0039757","article-title":"Blocking of PDL-1 interaction enhances primary and secondary CD8 T cell response to herpes simplex virus-1 infection","volume":"7","author":"Channappanavar","year":"2012","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4049\/jimmunol.182.2.980","article-title":"PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination","volume":"182","author":"Finnefrock","year":"2009","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01176\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:35:20Z","timestamp":1528115720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01176\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2018.01176"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01176","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"article-number":"1176"}}